The decreased levels of p-AKT and p-mTOR in these colon cancer cell lines validate the conclusion that the anti-tumor activity of berberine could be, at least in part, due to its action as an inhibitor of PI3K/AKT/mTOR pathway [53]. Here, AKT1 is linked to malignant colon neoplasm.